Scientists cast doubt on anti-aging red wine drugs
London, January 16 : Scientists have cast a shadow of doubt over drugs that might cheat the biology of ageing.

Read more on New Kerala

For the role of glibenclamide and pioglitazone drug mellitus in s. 11 does not compare insulin in diabetic patients. Authors: Raj Kumar Chohan, Mashor Ghulam Rasool, Ghulam Rasool Bhurgri, Shamim-u-Rehman, Mustafa DahriGhulam, anise-u-Rehman. Introduction: – diabetes comes from the Greek word for “siphon”, which is the first part and how many urine. The TRM “mellitus” comes from a word Laton “satisfied”, the “honey” and was used as the urine was low (Wheeler, 2004) Diabetic ketaocidosis is a life-threatening condition that certain data and hospitalization treatment. The recognition of this condition is most important, since even small delays can have an impact on survival (Nattrass, 2006). Involved in insulin-induced hypoglycemic episodes in people with diabetes. Probably the most important factor in the prescription, insulin-treated patients to achieve the objectives necessary to prevent glucose diabetic complications. The incidence of hypoglycemia reflects the current inadequancy Mathod of insulin that lead to elevated insulin levels inappropriately delivery ot especially after some people eat more food in cases of night blindness and is also a factor significant risk of heart disease and stroke (Heller, 2003). TYPES Diabetes MELLITUSTYPE 1 diabetes mellitus (IDDM) Type I diabetes in children of all ages, both sexes and all groups athenic. Type 1 diabetes usually occurs through mechanisms. It is the metabolic condition most common in children and adolescents (Bui, 2004). Type1diabetes is immune-mediated destruction of pancreatic B cells identified by insulin deficiency. This leads to a parameter common biochemical risk of hyperglycemia and ketoacidosis, but the clinical presentaion varies depending on the speed and degree of non-B-cell (Lambert & Bingley. 2005). Diabetes mellitus type II (NIDDM): Type II diabetes is a complex metabolic disorder associated with B cell dysfunction and insulin resistance with varying degrees of primary pathogenic factors, insulin resistance leads to diabetes type 2 and decreased insulin secretion, thus resulting in changes in the liver, skeletal muscle and B, pancreatic cells (Charles & Clark, 1996). Diabetes mellitus Gestational diabetes mellitus: women who develop glucose intolerance in late pregnancy and women with previously undiagnosed diabetes. SECONDARY diabetes mellitus: Diabetes is a disease caused by secondary pancreatic and endocrime system, genetic disorders or exposure to chemical agents. Type – I used diabetes as insluin diabetes mellitus (IDDM) is known, by the destruction of pancreatic beta cells that are known to produce marked inslulinType – I used diabetes as diabetes mellitus (IDDM), characterized by the destruction of pancreatic beta cells, insulin produced. Type 1 diabetes occurs most often in children and young adults, but it can occure at any age. (Anderson et al 2007). Diabetes Type-11 is not only uprward. A pancreas that does not produce enough insulin. Liver as the release of too much glucose, muscle cells, which do not readily as glucose. (McCarren 2008) Many genetic factors are involved in the development of diabetes. Due to determine new genetic methods, researchers are all candidate gene for non-insulin diabetes mellitus (Bernard, 1995). Women who had gestational diabetes more likely to develop type 11diabetes themselves. Pergnant women with diabetes are another vulnerable group. You need much more intensive prenatal care and close monitoring of blood glucose, blood pressure and weight. (jawed2006) The more weight children, the progression of childhood obesity into adulthood should be developed with early complications, IgpG2 including diabetes and cardiovascular disease. The diabetes is the form most common clinical accountingforabout diabetes of 90% of all cases, it is now epidemic in the world. 11diabetes mellitus type is caused by the infectious organism to use insulin, it is often the result of obesity and physical inactivity (WHO, 2007). PREVALACES & IINCIDENCE: Diabetes mellitus increases with age, the prevalence of diabetes was estimated 200 to 0. Persons 19% <20 years and 8 6% for patients> 20 years. It is considered to be geographical differences in the incidence of type 1 and type-11 diabetes mellitus. Scavandinvian has the highest incidence of type 1 diabetes in Finland, e. g, the incidence is 35/100 000 per year in the Pacific region has a much lower rate in Japan and China, the incidence is 1 to 3 / 100, 00 year Type 1 diabetes mellitus, Northern Europe and the United States have an intermediate rate (8to17/100, 000) per year. The prevalence of diabetes mellitus type 11 is higher in some Pacific island, an intermediate in countries like India and the United States, and relatively low in Russia and China. This variability is probably due to genetic resources, beharioral and environmental factors (Power, 2005). Prevalence Diabetes mellitus is also formed between the different ethnic groups in some countries it is common to ethnic Prevalence directly applicable to his age and more than 5% of the population has increased by more than 65 years have diabetes mellitus (David Owerback 1988). The world wide prevalence of diabetes has increased over the last two decades. The prevalence of diabetes mellitus diabetes TYPE11 is expected to type 11 diabetes is more common among Hispanic Native American, African, American and Asian Pacific Islanders than among non-Hispanic whites, the incidence is approximately equal to men and women in all population groups. Diabetes Type 11 is becoming more common as people live longer, and the prevalence of diabetes increases with age, it is also more common than previously seen in youth, in conjunction with prevalenceof the rise of obesity in children, although TYPE11 diabetes are still countries with estimated here, however, the incidence of diabetes in 2000and 2030th Country rank by Country 2000 people with diabetes (Milloin) Country diabtes people 2030 (in millions) 31e 7 India 47 India 79th China 20th 8 China 42nd 3 USA 17 7 United States 30 3 Indonesia 8th 4 Indonesia 21e 3 Japan 6 8 Pakistan 13 9 Pakistan 5 2 Brazil 11 3 Russian Federation 4th 6 Bangladesh 11th 1 Brazil 4th 6 Japan 8 9 Italy 4 3 Philippines 7th 8 Bangladesh 3rd 2 Egypt 6th 7 (Wareham & Forouhi 2OO6) drug treatment of diabetes: biguanides lower blood sugar, they increase the absorption of glucose and the use in skeletal muscle by reducing insulin resistance and decrease hepatic glucose production (gluconeogenesis). Decrease the sugar in the blood drops you additional low-and very low EXTENT OF MEASURE lipoproteins (LDL and VLDL), respectively. Metformin has a half-life of approximately 3 hours and is excreted unchanged in urine. Clinically with type 2 diabetes who are overweight and not treated with diet alone used metformin. Adverse effects are produced dose-related gastrointestinal e. g diarrhea, anorexia, nausea, lactic acidosis effects rare but potentially fatal toxic. (Dale, 2003). Insulin sensitivity improved by the activation of certain genes of lipid metabolism and carbohydrate synthesis and Rosigilitazone involved Piogiltazone are currently approved. Thiazolidinediones. Thiazolidinediones do not cause hypoglycemia when used alone, although they are generally made in combination with sulfonylureas. incouraging Some studies have thaiazolidiniones very positive effects on the heart, including reducing blood pressure and triglycerides and increase levels Cholestrol, including increased levels of HDL Cholestrol produced the good. You can block a molecule called 11 Best CSH which may play an important role in the metabolic syndrome and diabetes TYPE11. One study also indicated that rosiglitazone sugessted also beta cell function may improve and thus avoid the progression of diabetes. , Gain weight, anemia, increased risk of an accumulation of fluid can worson heart failure. Troglitazone, was withdrawn after several reports of heart failure. Liver failure, death Abd. Current Thiazoldinediones Don obviously not the same effects on the liver, although it represents even a few cases of liver damage. In patients with dietary requirements, failure of the election of a sulfonylurea or insulin therapy has been controversial and empric benefit of insulin treatment are based on studies, the significant improvement in receiver-reporting of diagnosed after intensive short-term therapy of diabetes mellitus type 2 untreated (Scarlett et al, 1984) Sulfonylurea further classified into two groups and generations of their efficacy, duration, drug interactions, patterns of side effects . Sulfonylureas increase insulin activity in cultured cells and stimulating the synthesis of glucose transporters (Jacobs et al 1998). A sulphonylurea drug should normally be the insulin secretagogue of choice, NICE (National Institute for Clinical Excellence) also shows that the generic drug was perscribed (Scsade and al1998). DESIGN OF THE RESEARCH, materials and methods: This study was conducted in deprtment the Pharmacololgy and Therapeutics, od Basic Medical Science Institute, Jinnah Postgraduate Medical Center, Karachi, under the supervision of the DRR Type: GhulamRsool Mashor Professo Partner and Head of Department of Pharmacology and Therapeutics with coworkers in the medical clinic and a filter Unit111 Clinic, Medical Department, JPMC, Karachi. Seventy NIDDM (type II) diabetic patients were initially enrolled in the study of filter Clinic Department of Medicine Division III, and the outpatient diabetes clinic. A dropped from 60 diabetic patients were associated throughout the duration of the study, 10 patients remaining were due to poor comlpiance or change in surface area. All patients are divided into two main groups, Group I and II in the group of patients in this study, after inclusion and exclusion criteria. The inclusion criteria selected groups: new non-diagnostic patient-sweet Diabtes insulin. Diagnsed patients with diabetes and a history that no medication. Having both sexes aged between 30 and 60. Patients diagnosed diabetes mellitus non-insulin Depedent were treated with pioglitazone. Patients diagnosed with non Imsulin Depedent mellitus who are treated with the drug glibenclamide. CRIRERIA EXCLUSION: Patients suffering from hypertension. Patients with liver disease. Patients with heart disease. Pregnancy and breastfeeding women. Patients with kidney disease. Patients with severe complications. EQUIPMENT: yaw. Lancet Hlder (TM2 many abbots EASYtouch ASEE 03). Glucometer (Medisense) optilim a key (Abbott). Nest trpis blood glucose (in vitro diagnostic (IVD Labortries Abbott Medisense UK Ltd, Abigngdon, Ox14ITR, Masdeu the United Kingdom). Cached between at least 30?, (4 ° -30 ° C) and a maximum 40 ° C (39 ° -86 ° F). Weight Machine model No. 1101 Lot No. 312th TANTIATA. DRUGS Tab: Daonil 5 mg (Aventis Pharma) Drug Category: sulphonylurea. Generic Name: glyburide. MFGLIC: 000007 No. . RegistrationNO. 000220MFG Date: 0 – 06EXP Date :7-10Lot NO: B230Tab: Pioz (Hilton Pharm) PvtLTd. Tab: Poizen 15mgDrug Category: Thaiazolinedione. Generic name: Pioglitazone hydrochloride. MFG LIC: O. 03270MFG Registration No. 000,136 Date :3-06EXP Date :3-o9Lot No: 6287Tab: Poizen (Hilton Pharma) PVT LTD. SETTINGS: fasting glucose (FBS). Random Blood Sugar (RBS). weight. Keywords: diabetes, non insulin , diabetes mellitus depedent insulin Daonil, Poizen, insulin. Results: Table 1 Weight and blood glucose observed the day of departure 0cm group 1 and group group11 1 Group 11 Pioglitazone Glibenclamide n = 27 n = 33 Weight 63. 37 + 2 25. ¯ ¯ 62. 7 + 15 56. 172nd fasting 7 + 13 32. ¯ ¯ 188. 42 + 12. o5 Random Blood Sugar 285. 11 + 15 532. ¯ ¯ 284. 18 + 17. 07 All Values are expressed as mean ± SEM. Figure 1 The weight and blood glucose levels observed at Baseline (Day-O) In Table shpwing weight (Kg’s) and glucose (msg/dl0 levels, which is observed at the base (day 0) in both groups 9group: 1 & group11) Groups: 1 Weight (Kg’s) mean + SEM) is 63e 37 ± 2 25 FPG 172e 13 ± 7 32, and random blood sugar 285e 11 ± 15 32 groups : 11 Weight (KG’s0 (mean + SEM) 62. 7 ± 1 56. FPG (mg/dl0 188. 42 ± 12. 05, blood sugar random 284. 18 ± 17. 03. Figure 2 shows the weight and blood glucose observed in core (day 0) in group 1 and group 11 by weight) 9 kg is the average value 63rd 37.62. 7, fasting glucose in (mg / dl) is 172. 71, 188 42 random blood glucose (mg / dl) 285. is 11 & 284. 18. TABLE: comments 2Peroidic in all settings Group1 Goup1 (pioglitazone) n = 27 P value Day 0 Day 45 Day 90-Day – Day-0to45 45-90 weight 63. 37 ± 2. 25 63. 63 ± 2. 26 63. 63 ± 2. 23> 0. 05 (NS)> 0. 05 (NS), fasting glucose 172. 7 ± 13. 32 165. 04 ± 8. 98 153. 37 ± 7. 59> 0. 05 (NS) 0. 05 (NS), Random Blood Sugar 285. 11 ± 15. 32 279. 78 ± 13. 63 255. 56 ± 12. 65> 0. 05 (NS)> 0. 05 (NS) All amounts are expressed as mean ± SEM. (NS) not significant. Table 2 following the regular observations of all parameters in group 1 (piogiltazone) (n 27 D) Weight Value (day 0 to day 45)> 0. 05 (NS). FPG> 0. 05 (NS) of random blood glucose> 0. 05 (NS) P-values of 90 days of weight> 0. 05 (N. S), FBS> 0. 05 (N. S) 7RBS> 0. 05 (N. S) SIGNIFICANTFIGURE NO: 2 showing the regular monitoring of all parameters in group 1 Tag0 day 45 and 90th day averages (kg weight) is 63. 37.63. 26, 63. 63, FBS (mg / dl) 172. 7165. 04,153. 37 RBS (mg / dl) 285. 11,279. 78,255. 56. TABLE NO3Peroidic observation in all settings group11 Group 11 (glibenclamide) N = 33 P value Day 0 Day 45 Day 90 Day-0-45-days from 45 to 90 weight 62. 7 ± 1. 56 65. 64 ± 2 10. 64. 55 ± 1. 92> 0. 05 (NS) 0. 05 (NS0 fasting 188. 42 ± 12. 05 168. 45 ± 10. 99 140 . 06 ± 5. 68> 0. 05 (NS)> 0. 05 (S) random blood glucose 284. 18 ± 17. 03 220. 12 ± 13. 39 170. 94 ± 5. 80 <0. 005 (MS) 0. 002 (MS0 (s) significantly (MS) significantAll moderate values are expressed as mean ± SEM. No3 Table: Here is the regular monitoring of all parameters in Goup: 11 groups: 11 with the drug ( glibenclamide), none of the patients (n = 33). It’s P-value on day 0 to day 45> weight 0. 05 (NS), FBS> 0. 05 (N. S) RBS <0. 005 (MS) <0. 01 – day 45 to day 90 Weight> 0. 05 (NS) FBS (0. 05) RBS <, 0. 002 (Mr S0 moderately important. Figure 3: Shwing regular observations all parameters in group 11 Weight 62. 7.65. 64.64. 55, FBS (mg / dl) 188. 42,168. 45 140. 06, RBS (mg / dl) 284. 18 220. 12, 170. 94 (day 0-day 45 to 90). DISCUSSION: In Denmark, Beck-al Nielsenet, Skillman TG (1981), published studies show that glibenclamide build it increases the number of receptors on monocytes of patients with diabetes mellitus type 11 Some patients were treated with diet and Cobin in the second generation agents as sulfonyureas. The number of insulin receptors in all patients were measured before treatment and after treatment. Intrvenous glucose test indicates impairent afterthe following the insulin secretion of the drug. But the patient, the drug during pioglitazone, drugs, certain results of inadequate secretion of insulin in the early development of drugs offer therapy. Clinical observation the second generation sulfonylureas may exercise its effects by potentiating insulin for other primary stimulators of insulin secreting drugs released. After studying WilliamC Dukworth et al (1972), aftr chronic treatment with sulfonylureas is well documented that plasma insulin levels were reduced in response to an oral glucose load. This occurs even if the apparent glucose tolerance is improved over pretreatment levels, this study clearly demonstrates that support for the study. The above result, Group 11 is correlated with research by Kimmel & Bonnie (run 2005) produced the same results as FBS reduced base and at the end of the study with a total of 23. 44%, while the results showed at the end of the study Peroid p-value was (p <0.001). Alvarsson Even Michael et al (2003) conducted a similar study and found, and general changes modification of 22 years. 11% FBS and 40 years. 88% at the end of the study were rbs p-value (p <0. 001). But one study (Stone & Brown conducted (2003 ) didnot our results correspond to the parameters of FBS and observers a reduction of 26. 22%. Conclusion: Given the discussion is the study obiovus glibenclamide was more effective, tolerable and safer than pioglitzone in a short period. The Diabetes mellitus is a chronic disease to prolong life. poor community can not afford it easily, based on the marketing of the drug in diabetic patients Pakistan, easy to use and more economical to purchase, in fact, people of ‘buy in a pharmacy without a perscription dr, you know, pharmacists and patients about the disease. dispirin As it is known as an anti-analgesic medication against diabetes in our states and other anti-diabetic compared. Refernces: Anderson J, Kendall, Perryman. S et al, “Diet and Diabetes Diabetes 2006.16 (3) :17-19-Bui H-type 1 diabetes in childhood 2006.3-Medicine ,1-3Bernhard diabetes Type 11 Diabetes Mellitus Diabetes Supply 1995.19 (100:12-17-CM Clark therapyin TYPE11 oral diabetes pharmacological properties and clinical application of current use of medications currently available Diabetes Spectrum 1998.11 (4) :211-221 . Carren Mr. species diabetes mellitus Diabetes 2006 10 (3) ,07-David Owerback NJ prevalence of diabetes in patients with diabetes 1988.02 (6) :31-32Dale MM, pharmacological treatment of diabetes mellitus 20035th edition: 287-391. Hypoglycemic Heller SR-diabetic ketoacidosis and hypoglycemia-Medicine 2006:34 (03) :102-110. Jawad F Untraveling the mystry the Diabetes’Diabetes 2006, 15 (3) :13-15th Jacobs, D – diabetes mellitus 1998, 6 (3); 1160126th Lambert Bingliy-facts and basic medical 2006.34 (6) :3-7. Natters M Ketoacdosis and hyperglycemia-Medicine 2006, 34 (3) :104-106. AC Epidemiology of Diabetes TYPE11 basic facts of diabetes Diabetes 2005, 1 (1) 7 9Scarlet oral treatment of diabetes type 11 sulphonylureas 1984, 16 (10), 3-9. Schade DS, et al A randomized controlled glimepiride placebo in patients with diabetes mellitus Diabetes-19998, 38 (7), 636-641. Warchman and Forouhi-Epidimology basic facts about diabetes, diabetes-Medicine 2006 34 (2), 57 — 60Wheeler Gd Aaccident discovery led to the Nobel Prize for Canadian reseachers, 2005 ,01-02. Report of the WHO Health Defiition diabetes mellitus and type of diabetes, 2007, 1:1-4.

Drug abuse does not have only a single definition; it has a wide range of definitions that relate to the use of a psychoactive drug or performance enhancing drug in order to achieve a non-therapeutic or non-medical effect. These are in sharp contrast to what we call responsible drug use. Drugs often abused include alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, methaqualone, and opium alkaloids. Other definitions of drug abuse can be classified into four main categories: public health definitions, mass communication and vernacular usage, medical definitions, and political and criminal justice definitions.

The definition of drug abuse by public health practitioners lays more stress on society than the individual. Their definition endeavors to look at the problem from a broader perspective and emphasizes the role of society, culture and availability. Instead of using the terms alcohol or drug “abuse,” a number of public health professionals prefer to use terms like “substance and alcohol type problems” or “harmful/problematic use” of drugs.

In British Columbia, the Health Officers Council in 2005 chose to challenge the simplistic black-and-white construction of the binary antonyms “use” vs. “abuse”. Instead, their model recognized a spectrum of use, varying from beneficial use to chronic dependence.

In recent times, neither the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM) nor the World Health Organization’s International Statistical Classification of Diseases and Related Health Problems (ICD) recognizes ‘drug abuse’ as a medical diagnosis. The DSM has opted for the term ‘substance abuse,’ which includes drug abuse and other things. The ICD, on the other hand, does not use either “substance abuse” or “drug abuse”, but prefers the term “harmful use” to cover physical or psychological harm to the user from use

WASHINGTON – Scientists has gone through an imitation procession about the cancer disease, where they have found its problematic behaviors in the direction of generating a medicine.With the intention of undertakings they have discovered just before a drug and it’s remedial. But there are some severe draw backs of cancer therapy,known as the wave’s smash up.

Tentative Drugs determine

Solitary measured quantities of the tentative drug have sheltered in cooperation rats as well as chimpanzees.Toxic measured quantity of the drugs energy, the scientists have delivered up their description during the Friday’s magazine of the journal Science.The purpose of current research was to observe the harmful and beneficial consequences of the amalgam into more aesthetic measures for the human beings.

Read the rest of this entry »